81 related articles for article (PubMed ID: 2113555)
1. Multiple calcium-mediated mechanisms regulate c-myc expression in HL-60 cells.
Salehi Z; Niedel JE
J Immunol; 1990 Jul; 145(1):276-82. PubMed ID: 2113555
[TBL] [Abstract][Full Text] [Related]
2. Complex regulation of macrophage colony-stimulating factor in the HL-60 promyelocytic cell line.
Sater RA; Cripe LD; Taylor JD; Niedel JE
J Immunol; 1991 Jul; 147(2):633-7. PubMed ID: 2071899
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of retinoic acid and calcium ionophore A23187 on differentiation, c-myc expression, and membrane tyrosine kinase activity in human promyelocytic leukemia cell line HL-60.
Chapekar MS; Hartman KD; Knode MC; Glazer RI
Mol Pharmacol; 1987 Feb; 31(2):140-5. PubMed ID: 3100942
[TBL] [Abstract][Full Text] [Related]
4. Absence of phorbol ester-induced down-regulation of myc protein in the phorbol ester-tolerant mutant of HL-60 promyelocytes.
Gailani D; Cadwell FJ; O'Donnell PS; Hromas RA; Macfarlane DE
Cancer Res; 1989 Oct; 49(19):5329-33. PubMed ID: 2670202
[TBL] [Abstract][Full Text] [Related]
5. Effect of phorbol myristate acetate on c-myc, beta-actin, and FV gene expression in morphologically recognizable human megakaryocytes: a kinetic analysis employing in situ hybridization.
Gewirtz AM; Shen YM
Exp Hematol; 1990 Sep; 18(8):945-52. PubMed ID: 2201557
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional down-regulation of c-myc expression by protein synthesis-dependent and -independent pathways in a human T lymphoblastic tumor cell line.
Bading H; Moelling K
Cell Growth Differ; 1990 Mar; 1(3):113-7. PubMed ID: 2127692
[TBL] [Abstract][Full Text] [Related]
7. Requirements for the simultaneous presence of phorbol esters and calcium ionophores in the expression of human T lymphocyte proliferation-related genes.
Kumagai N; Benedict SH; Mills GB; Gelfand EW
J Immunol; 1987 Sep; 139(5):1393-9. PubMed ID: 3114365
[TBL] [Abstract][Full Text] [Related]
8. Two different molecular pathways account for low IL-2 receptor and c-myc mRNA expression by lpr Lyt-2- L3T4- T cells.
Katagiri K; Katagiri T; Yokota S; Eisenberg RA; Cohen PL; Ting JP
J Immunol; 1988 Sep; 141(6):2145-52. PubMed ID: 3139753
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of cellular oncogene expression in mouse lymphocytes. II. Regulation of c-fos and c-myc gene expression.
Schneider-Schaulies J; Schimpl A; Wecker E
Eur J Immunol; 1987 May; 17(5):713-8. PubMed ID: 3556196
[TBL] [Abstract][Full Text] [Related]
10. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional control of c-myc gene expression during stimulation of murine B lymphocytes.
Buckler AJ; Rothstein TL; Sonenshein GE
J Immunol; 1990 Jul; 145(2):732-6. PubMed ID: 2195118
[TBL] [Abstract][Full Text] [Related]
12. Modulation of a constitutive transcriptional block at exon-1 controls human c-myc oncogene expression.
Re GG; Antoun GR; Zipf TF
Oncogene; 1990 Aug; 5(8):1247-50. PubMed ID: 1697411
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
Morello D; Lavenu A; Babinet C
Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
[TBL] [Abstract][Full Text] [Related]
14. Altered regulation of c-myc in an HL-60 differentiation resistant subclone, HL-60-1E3.
Ely CM; Leftwich JA; Chenevix-Trench G; Hall RE; Westin EH
Cancer Res; 1987 Sep; 47(17):4595-600. PubMed ID: 3476196
[TBL] [Abstract][Full Text] [Related]
15. Uncoupling of c-myc mRNA expression from G1 events in human T lymphocytes.
Friedrich B; Gullberg M; Lundgren E
Anticancer Res; 1988; 8(1):23-8. PubMed ID: 3128958
[TBL] [Abstract][Full Text] [Related]
16. Bombesin induction of c-fos and c-myc proto-oncogenes in Swiss 3T3 cells: significance for the mitogenic response.
Rozengurt E; Sinnett-Smith JW
J Cell Physiol; 1987 May; 131(2):218-25. PubMed ID: 3108267
[TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant human transforming growth factor-beta 1 or/and interleukin-6 on growth inhibition and proto-oncogene c-myc expression in human leukemia cells.
Feng R; Shen S; Hui H; Jin M
Chin Med J (Engl); 1997 Nov; 110(11):847-50. PubMed ID: 9772416
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific post-transcriptional regulation of c-myc expression in normal and H-2K/human c-myc transgenic mice.
Morello D; Asselin C; Lavenu A; Marcu KB; Babinet C
Oncogene; 1989 Aug; 4(8):955-61. PubMed ID: 2668846
[TBL] [Abstract][Full Text] [Related]
19. C-myc expression is down-regulated in mafosfamide-treated HL-60 cells undergoing apoptosis.
Davidoff AN; Mendelow BV
Anticancer Res; 1993; 13(4):1167-70. PubMed ID: 8352540
[TBL] [Abstract][Full Text] [Related]
20. Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60).
Kraft AS; Baker VV; May WS
Oncogene; 1987 May; 1(2):111-8. PubMed ID: 3325877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]